Trinity Biotech TRIB Cash Flow Statement (2009-2025)

NASDAQ TRIB
$8.02 -0.17 (-2.08%)
As of: Oct 20, 2026 · 2:06 PM EDT
Reported Financials

Trinity Biotech Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2025

Trinity Biotech cash flow statement data for the quarter ended Jun 2025. This cash flow statement covers 65 quarters of results from Mar 2009 through Jun 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025
Operating Activities
Net Income
-1.47M7.33M-9.65M1.60M-0.78M1.32M-1.26M-12.28M-9.71M-8.95M-10.08M-5.81M-5.99M-6.72M-5.50M-3.32M-6.76M-4.76M-16.96M
Depreciation and DepletionDep. & Depletion
0.58M0.55M0.15M432.000.05M0.48M0.45M351.000.31M0.17M0.00M164.00-0.07M0.26M0.32M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.24M0.23M0.23M228.000.21M0.27M0.22M251.000.18M0.06M0.46M527.000.22M0.34M0.11M
Depreciation & Amortization (CF)Dep. & Amort.
0.58M0.55M0.15M432.000.05M0.48M0.45M351.000.31M0.17M0.00M164.00-0.07M0.26M0.32M
Share-based CompensationStock Comp.
0.31M0.25M0.15M0.20M0.12M0.12M1.32M1.36M0.98M0.74M-1.01M0.81M0.11M0.25M0.14M
Deferred Taxes
0.40M0.02M
Gains from Sales and DivestituresGains Divest
0.00M-12.72M12.72M
Asset Writedowns and ImpairmentWritedown
6.07M12.14M0.88M2.29M3.03M0.29M0.96M
Other non-cash itemsOther Non-Cash
-2.77M-1.49M4.90M-0.69M1.00M-0.40M3.06M0.20M-0.07M-0.18M2.60M-0.15M-0.06M0.06M7.01M
Non-cash ItemsNon-Cash Items
1.31M9.72M4.68M4.06M4.46M2.38M6.56M-0.22M0.27M0.53M0.18M-1.35M-3.10M-2.74M-1.05M-1.85M-2.82M-1.76M-2.84M
Change in Working Capital
1.47M-2.55M10.16M1.83M-3.16M-1.78M-1.88M-1.28M4.76M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
Other Operating ActivitiesOther Ops.
0.00M0.00M0.00M
Cash from OperationsCash from Ops.
2.78M7.17M14.84M5.89M1.21M0.61M4.33M-1.49M-1.93M0.68M2.28M-2.72M-4.42M-4.66M0.25M-2.82M-1.10M-3.62M3.35M
Investing Activities
Capital ExpendituresCapex
-0.39M-0.27M-0.57M-0.16M-0.14M-0.32M-0.48M-0.27M-0.15M-0.13M-0.25M-0.07M-0.07M-0.11M-0.16M
Change in Property, Plant and EquipmentChange in PP&E
0.39M0.27M0.57M0.16M0.14M0.32M0.48M0.27M0.15M0.13M0.25M0.07M0.07M0.11M0.16M
Change in IntangiblesChange Intangibless
-1.74M-1.69M-1.91M-1.55M-1.66M-1.00M-0.66M-0.70M-0.41M-0.49M-0.64M-1.40M-3.10M-2.59M-2.58M
Acquisitions
-12.50M-0.40M0.00M
Divestments
-0.27M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.27M12.50M0.40M0.00M
Purchase of InvestmentsInvestments Purchased
-1.40M
Other Investing ActivitiesOther investing
-2.00M-2.00M-2.00M-2.00M
Cash from Investing ActivitiesCash from Investing
-2.13M-1.96M-2.48M-1.72M-1.80M-1.32M-1.14M-1.33M27.86M-0.89M-0.89M-13.96M-3.17M-3.10M-2.74M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
4.52M1.76M80.02M0.00M4.85M0.15M21.68M6.50M
Long-Term Debt RepaymentsLT Debt Repayment
-86.73M-34.50M-155.73M-0.02M-10.05M-20.10M20.10M
Non-Current Debt
4.52M1.76M166.75M34.50M155.73M0.02M4.85M10.20M20.10M-20.10M21.68M6.50M
Net Debt Issuances and RepaymentsNet Debt Issuance
4.52M1.76M166.75M34.50M155.73M0.02M4.85M10.20M20.10M-20.10M21.68M6.50M
Change in Capital Stock
Common Stock IssuedStock Issued
0.06M
Net Shares Issued and RepurchasedNet Shares Issued
0.06M
Net Equity Issued and RepurchasedNet Equity Issued
0.06M
Dividend Payments
Dividends Paid - Common and PrefferdDiv Paid (Total)
Other financing activitiesOther financing
-0.74M-0.73M-0.74M-0.77M-0.73M-0.68M-0.58M-0.60M-0.59M-0.57M-0.56M-0.56M-0.60M-0.68M-0.67M
Cash from Financing ActivitiesCash from Financing
-2.16M-1.90M-3.62M-2.20M-2.74M-0.73M-3.59M-12.87M4.33M-2.37M-1.85M1.61M-13.45M-2.43M-1.77M18.85M3.92M4.24M1.81M
Additional items
Exchange Rate EffectFX Effect
0.10M-0.15M0.17M0.18M-0.15M-0.18M0.03M0.01M0.09M0.01M-0.16M0.02M-0.11M0.01M-0.09M
Change in Cash
-0.20M4.34M9.42M3.19M-1.66M-1.14M-1.73M-16.08M0.59M-3.02M-0.71M-2.44M9.99M-7.98M-2.41M2.06M-0.35M-2.48M2.42M
Ending Cash Balance
15.57M19.91M11.45M32.28M28.62M28.62M-1.47M10.01M10.45M7.25M-19.22M4.15M14.23M6.26M0.33M5.78M5.32M2.84M0.19M1.55M
Free Cash FlowFCF
2.78M7.17M14.84M5.89M1.60M0.88M4.90M-1.33M-1.79M1.00M2.75M-2.44M-4.27M-4.54M0.50M-2.75M-1.03M-3.51M3.51M
Net Cash FlowNCF
0.62M5.27M11.23M3.70M-3.66M-2.08M-1.73M-16.08M0.59M-3.02M-0.71M-2.44M9.99M-7.98M-2.41M2.06M-0.35M-2.48M2.42M
Interest Paid
-2.00M-0.01M-2.00M-1.29M0.00M0.00M2.59M0.00M0.01M0.00M0.00M0.00M0.01M0.00M0.02M
Income Taxes PaidTaxes Paid
-0.03M-0.14M-1.14M0.19M-0.07M1.10M-1.19M-0.15M-0.03M0.00M-0.02M0.00M-0.27M0.40M0.00M1.18M-0.13M0.59M

Trinity Biotech Cash Flow Statement API

Pull Trinity Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRIB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY